Loading
1 insider bought €5.9M of shares over the last 90 days, the latest by Wu Mansheng, filed 10 Sept 2026.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€11M
14 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleWu Mansheng4 buys
Since the insiders bought
- -31.0%Entry HK$0.58 · Close 21 Oct 2026 HK$0.40
- -57.9%Entry HK$0.28 · Close at T+365 HK$0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,261 of 26,304 companies
30.0
score / 100
Value26
Quality34
FCF yld-4.7%
Earn yld-1.1%
EV/EBITDA·
ROE-5.1%
Gross mgn49%
Net mgn-17%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.40
Analyst consensus
Income statement
RevenueHK$33.1M
Gross profitHK$16.2M49% margin
EBITDA-HK$17.1M-52% margin
Net income-HK$5.5M1.5% margin
Valuation
P/Book1.9x
Beta0.83
Balance sheet & cash
Market capHK$500.5M
Total debtHK$28M
Free Cash Flow-HK$23.9M
Debt / Equity12%
Profitability & ownership
ROE-5.1%
ROA0.5%
% insiders27.1%
% institutions15.6%
Last declaration on 10 September 2026
Declarations15 total
121,565,275 shares@ HK$0.4310.10% mcap61.9% of flowShareXHKGHKEX:DA20260910E00239
Canonical exit: 6 Dec 2026 (T+90)
1,890,000 shares@ HK$0.57020.17% mcap1.3% of flowShareXHKGHKEX:DA20260813E00443
Canonical exit: 5 Nov 2026 (T+90)
55,000,000 shares@ HK$0.452.96% mcap28.9% of flowShareXHKGHKEX:DA20260422E00497
Canonical exit: 19 Jul 2026 (T+90)
15,000,000 shares@ HK$0.450.81% mcap7.9% of flowShareXHKGHKEX:DA20260421E00610
Canonical exit: 14 Jul 2026 (T+90)
147,000,000 sharesShareXHKGHKEX:DA20260227E00269
30,778,750 shares@ HK$0.3049.7% of flowShareXHKGHKEX:DA20230918E00327
Canonical exit: 19 Oct 2023 (T+90)
30,778,750 shares@ HK$0.3050.3% of flowShareXHKGHKEX:DA20230810E00362
Canonical exit: 7 Nov 2023 (T+90)
7,300,000 sharesShareXHKGHKEX:DA20230724E00336
Canonical exit: 19 Oct 2023 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20210422E00521
Canonical exit: 15 Jul 2021 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20210422E00525
Canonical exit: 15 Jul 2021 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20210422E00531
Canonical exit: 15 Jul 2021 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20200525E00148
Canonical exit: 18 Aug 2020 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20200525E00150
Canonical exit: 18 Aug 2020 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20200525E00154
Canonical exit: 18 Aug 2020 (T+90)
3,180,000 sharesShareXHKGHKEX:DA20200525E00157
Canonical exit: 18 Aug 2020 (T+90)
15 of 15 declarations
About BFB Health Ltd.
BFB Health Ltd., a Hong Kong media company valued at HKD 500,485,632, has only purchases among its 15 filings from 9 filers: 14 purchases, 6 of them with an amount worth EUR 11,401,824 in total (median EUR 1,068,363), and one filing of another nature. No sale is on record. Insiders hold 27.1% of the shares.
Wu Mansheng, a director, filed 5 times including 4 purchases, and made the largest ones: EUR 5,734,303 on September 7, 2026 and EUR 2,681,811 on April 20, 2026. The third, EUR 1,075,440, is Li Wei's, a director, on August 9, 2023; Li Wei has 3 filings, all purchases. Law Chi Hung, Leung Tat Yin and Wong Ching Cheung each reported one purchase.
Read moreShow less
On May 20, 2020, four insiders bought on the same day. Filings split into 4 in 2020, 3 in 2021, 3 in 2023 and 5 in 2026, for trades from May 20, 2020 to September 7, 2026. The 5 filings of 2026 fall within the last twelve months, 4 of them purchases. Filings appear a median of 5 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
